Please use this identifier to cite or link to this item:
Title: Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study
Author: Zamora-Ros, Raul
Alghamdi, Muath A.
Cayssials, Valerie
Franceschi, Silvia
Almquist, Martin
Hennings, Joakim
Sandström, Maria
Tsilidis, Konstantinos K.
Weiderpass, Elisabete
Boutron-Ruault, Marie-Christine
Hammer Bech, Bodil
Overvad, Kim
Tjønneland, Anne
Petersen, Kristina E. N.
Mancini, Francesca Romana
Mahamat-Saleh, Yahya
Bonnet, Fabrice
Kühn, Tilman
Fortner, Renée T.
Boeing, Heiner
Trichopoulou, Antonia
Bamia, Christina
Martimianaki, Georgia
Masala, Giovanna
Grioni, Sara
Panico, Salvatore
Tumino, Rosario
Fasanelli, Francesca
Skeie, Guri
Braaten, Tonje
Lasheras, Cristina
Salamanca Fernández, Elena
Amiano, Pilar
Chirlaque, María Dolores
Barricarte, Aurelio
Manjer, Jonas
Wallström, Peter
Bueno de Mesquita, H. Bas
Peeters, Petra H. M.
Khaw, Kay-Tee
Wareham, Nicholas J.
Schmidt, Julie A.
Aune, Dagfinn
Byrnes, Graham
Scalbert, Augustin
Agudo, Antonio
Rinaldi, Sabina
Keywords: Càncer
Cafè (Beguda)
Coffee drink
Issue Date: 10-Dec-2018
Publisher: Springer Nature
Abstract: PURPOSE: Coffee and tea constituents have shown several anti-carcinogenic activities in cellular and animal studies, including against thyroid cancer (TC). However, epidemiological evidence is still limited and inconsistent. Therefore, we aimed to investigate this association in a large prospective study. METHODS: The study was conducted in the EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, which included 476,108 adult men and women. Coffee and tea intakes were assessed through validated country-specific dietary questionnaires. RESULTS: During a mean follow-up of 14 years, 748 first incident differentiated TC cases (including 601 papillary and 109 follicular TC) were identified. Coffee consumption (per 100 mL/day) was not associated either with total differentiated TC risk (HRcalibrated 1.00, 95% CI 0.97-1.04) or with the risk of TC subtypes. Tea consumption (per 100 mL/day) was not associated with the risk of total differentiated TC (HRcalibrated 0.98, 95% CI 0.95-1.02) and papillary tumor (HRcalibrated 0.99, 95% CI 0.95-1.03), whereas an inverse association was found with follicular tumor risk (HRcalibrated 0.90, 95% CI 0.81-0.99), but this association was based on a sub-analysis with a small number of cancer cases. CONCLUSIONS: In this large prospective study, coffee and tea consumptions were not associated with TC risk.
Note: Versió postprint del document publicat a:
It is part of: European Journal of Nutrition, 2018
Related resource:
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
Coffee and tea & TC_EurJNutr_final.pdf593.47 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.